ADMA
ADMA Biologics·NASDAQ
--
--(--)
--
--(--)
3.83 / 10
Netural
Analyst consensus is a single Strong Buy, yet historical performance is negative. Fund flow is strong (7.67/10) with good inflow ratios but negative trends across all size categories, indicating liquidity support despite price decline.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-05-08
InstitutionRaymond James
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for ADMA?
- ADMA holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.83/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
